Welcome to our dedicated page for Flora Growth news (Ticker: FLGC), a resource for investors and traders seeking the latest updates and insights on Flora Growth stock.
Flora Growth Corp (FLGC) operates at the intersection of cannabis cultivation and pharmaceutical distribution, maintaining a vertically integrated model across 15+ countries. This page delivers essential updates about corporate milestones, regulatory compliance, and market expansion efforts.
Investors and industry observers will find comprehensive coverage of earnings reports, strategic partnerships, product launches, and operational developments. Our aggregation ensures you stay informed about FLGC’s commercial wholesale activities, consumer brand portfolio, and pharmaceutical-grade medical solutions.
Key updates include international supply chain advancements, CBD product innovations, and compliance achievements in regulated markets. Bookmark this page for real-time access to Flora Growth’s press releases and third-party analysis, curated to support informed decision-making.
Flora Growth Corp. (NASDAQ: FLGC) has successfully regained compliance with Nasdaq's minimum bid price requirement. The company received confirmation from Nasdaq on August 19, 2025, after maintaining a closing bid price above $1.00 per share for 10 consecutive trading days from August 4-15, 2025.
This development resolves the compliance issue that began on February 25, 2025, when Nasdaq notified Flora of its non-compliance with the minimum bid price requirement. The company had been given a 180-calendar day period to meet the listing standard. With this requirement now satisfied, Flora remains fully compliant with all Nasdaq listing standards and will continue trading on the exchange.
Flora Growth Corp. (NASDAQ: FLGC) has announced a 1-for-39 share consolidation of its issued and outstanding common shares, effective August 3, 2025. The consolidation aims to increase the bid price of common shares to regain compliance with Nasdaq Capital Market listing requirements.
Trading on a post-consolidation basis will begin on August 4, 2025. For every 39 existing shares, shareholders will receive one new share, with fractional shares rounded up to the next whole share. The stock will continue trading under the ticker "FLGC" with a new CUSIP number 339764300.
The consolidation was approved by shareholders on June 30, 2025, authorizing a ratio range of 1-for-10 up to 1-for-100. No action is required from shareholders holding shares electronically or through brokers.
Flora Growth Corp. (NASDAQ: FLGC) held its 2025 Annual and Special Meeting of Shareholders, where several key proposals were voted upon. The company announced the election of five directors to the board: Clifford Starke, Sammy Dorf, Edward Woo, Manfred Leventhal, and Harold Wolkin.
Shareholders approved multiple significant proposals, including: the reappointment of Davidson & Company LLP as auditors, an increase in the 2022 Plan share issuance limit from 2.5M to 4.5M shares, and authorization for the Board to implement a share consolidation ratio between 10:1 and 100:1 within one year. Additionally, the repricing and amendment of vesting terms for certain Stock Appreciation Rights was approved.
Notably, shareholders rejected Proposal 4, which sought approval for granting Stock Appreciation Rights to the company's CEO, CFO, and Executive Chairman.
Flora Growth Corp. (NASDAQ: FLGC) reported its 2024 financial results with significant strategic developments. The company appointed Sammy Dorf, Verano Co-Founder, as Executive Chairman to spearhead expansion into the THC-infused beverage market. Flora completed a specialized beverage facility and launched THC-infused brands Melo and Cloud Cola, securing distribution through Sunshine State Distributing.
Key financial activities include raising $0.7 million through selling 425,000 common shares at $1.67 per share and $3.6 million through a registered direct offering of 2,850,000 shares at $1.25 per share. The company signed a supply agreement with Curaleaf for importing medical cannabis to Germany and appointed Dr. Manfred Ziegler as Managing Director in Germany.
Flora launched new products including Element water pipe and Compass Rise Crimson under its Vessel brand, and appointed Patrick Moloney, holder of over 300 patents, as Head of Product Development. The company also expanded its European presence by launching a Parallel Import Business in Germany.
Flora Growth Corp. (NASDAQ: FLGC) has appointed Patrick Moloney as Head of Product Development for its accessory brand, Vessel. Moloney brings over 20 years of product innovation experience, having previously served as Design Manager at Dyson and Senior Manager of New Sciences at British American Tobacco.
Moloney is credited with over 300 patents, including the Dyson Supersonic Hairdryer and Dyson Airblade Tap. At British American Tobacco, he contributed to over 170 inventions and 120 patent filings, representing approximately 25% of the company's total filings during his tenure.
In his new role, Moloney will oversee Vessel's product development, focusing on innovation and enhancing product quality in the premium cannabis accessories market. CEO Clifford Starke highlighted Moloney's expertise in heat combustion and his potential impact on Vessel's growth and market expansion.
Flora Growth Corp. (FLGC) announced that its Board of Directors granted Clifford Starke 900,000 Restricted Stock Awards on December 15, 2024, which fully vested immediately. Prior to this grant, Starke owned 1,346,902 Common Shares, representing 7.80% of outstanding shares. Following the acquisition, Starke's holdings increased to 3,850,886 Common Shares on a fully-diluted basis, representing approximately 16.39% of the company's outstanding shares. The acquisition was made for investment purposes, with Starke maintaining the right to acquire or dispose of securities based on market conditions and company prospects.
Flora Growth Corp. (NASDAQ: FLGC) has announced the closing of a $3.6 million registered direct offering to institutional investors. The company sold 2,850,000 Common Shares at a price of $1.25 per share. The proceeds will be used for general corporate purposes and working capital.
The offering was conducted through Aegis Capital Corp. as the Exclusive Placement Agent and was made pursuant to an effective shelf registration statement on Form S-3. The transaction was supported by legal counsel from Dorsey & Whitney LLP for the Company and Kaufman & Canoles, P.C. for Aegis Capital Corp.
Flora Growth Corp. (NASDAQ: FLGC) has announced a $3.6 million registered direct offering with institutional investors. The offering comprises 2,850,000 Common Shares priced at $1.25 per share. The transaction is expected to close around December 16, 2024.
Aegis Capital Corp. is serving as the Exclusive Placement Agent, with Dorsey & Whitney LLP acting as company counsel. The offering is being conducted under an effective shelf registration statement on Form S-3. The company plans to use the net proceeds for general corporate purposes and working capital.
Flora Growth Corp. (NASDAQ: FLGC) has announced its plans to apply for participation in upcoming cannabis pilot programs in Germany, overseen by the Federal Ministry for Agriculture and Food (BMEL). The initiative will be led by Executive Chairman Sammy Dorf, who previously secured over 40 licenses across 14 U.S. states, and Managing Director for Germany Manfred Ziegler.
The pilot programs aim to reduce illicit markets, enhance health prevention, and provide data for cannabis-related discussions. The company will be supported by TruHC's executive team, led by Hendrik Knopp, who has previous experience winning the first tender for medical cannabis cultivation in Germany with Tilray.
FAQ
What is the current stock price of Flora Growth (FLGC)?
What is the market cap of Flora Growth (FLGC)?
